![Canoweissmon [BT10-011] (2023 Regionals Finalist) [Xros Encounter Promos]](https://cdn.shopify.com/s/files/1/0579/0960/8613/files/501762.jpg?v=1745609686)
Pay in installments of $6.50 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Canoweissmon [BT10-011] (2023 Regionals Finalist) [Xros Encounter Promos]Set: Xros Encounter Promos Card type: Digimon Rarity: Promo Digi type: Sky Dragon Play Cost: 8 Form: Ultimate Attribute: Vaccine Digivolve Cost: 4 Digivolve Cost Level: 4 [Digivolve: 3 from Lv. 4 w [Gammamon in name] [Your Turn] [Once Per Turn] When one of your Tamers becomes suspended, this Digimon gets +2000 DP for the turn. Then, if this Digimon has 12000 DP or more, it gains [Security Attack +1] for the turn. (This Digimon checks 1 additional
| Set: | Xros Encounter Promos |
| Card type: | Digimon |
| Rarity: | Promo |
| Digi type: | Sky Dragon |
| Play Cost: | 8 |
| Form: | Ultimate |
| Attribute: | Vaccine |
| Digivolve Cost: | 4 |
| Digivolve Cost Level: | 4 |
[Digivolve: 3 from Lv.4 w/[Gammamon in name]
[Your Turn] [Once Per Turn] When one of your Tamers becomes suspended, this Digimon gets +2000 DP for the turn. Then, if this Digimon has 12000 DP or more, it gains [Security Attack +1] for the turn. (This Digimon checks 1 additional security card.)
[All Turns] This Digimon gains all effects of cards with [Gammamon] in their names in this Digimon's digivolution cards.
[All Turns] This Digimon gains all effects of cards with [Gammamon] in their names in this Digimon's digivolution cards.
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.7 ★★★★★
Based on 25 reviews
Sort
Product Reviews
★★★★★ 5
Technical in detail, but highly readable.
Format: Hardcover
This is an excellent commentary on Revelation alone or alongside other commentaries. Schreiner interacts with other scholars in the field, summarizing the interpretive options, and constantly reaches a theologically solid conclusion. You won't be disappointed!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 20, 2024
★★★★★ 3
Not great, not bad
Format: Hardcover
There are a few sections that are stand-outs. He's a pleasant writer, but over all not much new ground plowed.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 26, 2023
★★★★★ 5
great review
Format: Paperback
This study guide helped me a lot for Nursing program Pathophysiology. Loved the class, maybe in next life I can try medical school.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 1, 2026
★★★★★ 5
No issues
Format: Paperback
Good condition
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 20, 2026
★★★★★ 5
Helped me ace my final!
Format: Paperback
I strongly recommend this study guide to anyone who needs to understand and apply the pathophysiology in a final exam. The original book was the textbook for my pathophysiology course- it is over 1000 pages and overwhelming.
This study guide broke down the important aspects of each chapter into very doable practice questions. The answer guide at the back has perforations - so I tore mine out and it made it so much easier to follow along and study with this guide.
If you are struggling to learn/memorize/understand/apply all the pathophysiology concepts-I strongly suggest using this study guide. It really helped me get through my exam - and I am not a good test taker.
Good luck in your studies!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 22, 2022